Mediclinic International PLC (LON:MDC) had its price objective dropped by equities research analysts at Credit Suisse Group AG from GBX 1,120 ($13.99) to GBX 1,045 ($13.06) in a research note issued on Friday. The firm presently has an “outperform” rating on the stock. Credit Suisse Group AG’s target price points to a potential upside of 41.22% from the company’s current price.

A number of other analysts have also recently issued reports on MDC. HSBC decreased their target price on Mediclinic International PLC from GBX 920 ($11.49) to GBX 745 ($9.31) and set a “reduce” rating for the company in a report on Friday. JPMorgan Chase & Co. reiterated a “neutral” rating and set a GBX 1,160 ($14.49) target price on shares of Mediclinic International PLC in a report on Tuesday, August 23rd. Jefferies Group decreased their target price on Mediclinic International PLC from GBX 833 ($10.41) to GBX 812 ($10.14) and set a “hold” rating for the company in a report on Wednesday, September 28th. Finally, Citigroup Inc. cut Mediclinic International PLC to a “neutral” rating and set a GBX 1,090 ($13.62) target price for the company. in a report on Monday, September 12th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of GBX 949 ($11.86).

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Mediclinic International PLC (LON:MDC) opened at 755.94 on Friday. The stock’s 50 day moving average is GBX 895.40 and its 200-day moving average is GBX 959.22. The stock’s market capitalization is GBX 5.57 billion. Mediclinic International PLC has a 12 month low of GBX 729.00 and a 12 month high of GBX 1,184.00.

The firm also recently announced a dividend, which will be paid on Monday, December 12th. Shareholders of record on Thursday, November 24th will be given a GBX 3.20 ($0.04) dividend. This represents a dividend yield of 0.41%. The ex-dividend date of this dividend is Thursday, November 24th.

Mediclinic International PLC Company Profile

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.

Receive News & Stock Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related stocks with our FREE daily email newsletter.